Forvis Mazars Wealth Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,626
| Closed | -$360K | – | 296 |
|
|
2019
Q3 | $360K | Sell |
3,626
-782
| -18% | -$74.3K | 0.03% | 209 |
|
|
2019
Q2 | $407K | Sell |
4,408
-116
| -3% | -$11K | 0.03% | 183 |
|
|
2019
Q1 | $427K | Buy |
4,524
+336
| +8% | +$29.4K | 0.04% | 179 |
|
|
2018
Q4 | $268K | Buy |
4,188
+658
| +19% | +$48.6K | 0.03% | 191 |
|
|
2018
Q3 | $316K | Sell |
3,530
-188
| -5% | -$16.6K | 0.03% | 189 |
|
|
2018
Q2 | $295K | Buy |
3,718
+8
| +0.2% | +$664 | 0.03% | 197 |
|
|
2018
Q1 | $331K | Buy |
3,710
+226
| +6% | +$21.7K | 0.03% | 187 |
|
|
2017
Q4 | $364K | Sell |
3,484
-418
| -11% | -$47.2K | 0.04% | 181 |
|
|
2017
Q3 | $569K | Sell |
3,902
-19
| -0.5% | -$2.59K | 0.06% | 126 |
|
|
2017
Q2 | $509K | Buy |
3,921
+104
| +3% | +$12.7K | 0.06% | 136 |
|
|
2017
Q1 | $475K | Buy |
3,817
+133
| +4% | +$15.9K | 0.06% | 128 |
|
|
2016
Q4 | $426K | Buy |
3,684
+141
| +4% | +$15.7K | 0.06% | 132 |
|
|
2016
Q3 | $370K | Buy |
3,543
+445
| +14% | +$48.2K | 0.05% | 130 |
|
|
2016
Q2 | $306K | Buy |
3,098
+3
| +0.1% | +$310 | 0.05% | 139 |
|
|
2016
Q1 | $310K | Sell |
3,095
-1,155
| -27% | -$119K | 0.05% | 138 |
|
|
2015
Q4 | $509K | Sell |
4,250
-248
| -6% | -$28.7K | 0.08% | 109 |
|
|
2015
Q3 | $487K | Buy |
4,498
+355
| +9% | +$44.1K | 0.09% | 107 |
|
|
2015
Q2 | $479K | Sell |
4,143
-2
| -0% | -$229 | 0.07% | 112 |
|
|
2015
Q1 | $478K | Buy |
4,145
+73
| +2% | +$8.72K | 0.07% | 112 |
|
|
2014
Q4 | $455K | Buy |
+4,072
| New | +$429K | 0.07% | 102 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Forvis Mazars Wealth Advisors's CELG Position: Q4 2019 in Review
Forvis Mazars Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,626 shares — an estimated $360K sold.
Forvis Mazars Wealth Advisors first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $569K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Forvis Mazars Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Forvis Mazars Wealth Advisors sold 3,626 Celgene Corp shares in Q4 2019, an estimated $360K.
- Forvis Mazars Wealth Advisors first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
- Forvis Mazars Wealth Advisors's Celgene Corp position peaked at $569K in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Forvis Mazars Wealth Advisors's 13F filing for Q4 2019, filed 13 Jan 2020.